Timothy J. Barberich

Chairman of the Board and Chief Executive Officer

Sepracor was founded in 1984 by its Chairman and Chief Executive Officer, Timothy Barberich.  Mr. Barberich served as President and Chief Executive Officer from 1984 through 1999, at which time Mr. Barberich was elected Chairman of the Board of Directors. Sepracor became a publicly traded company in 1991 and spun out four publicly traded companies: Chirex (which, through a series of acquisitions, was ultimately acquired by Rhodia in 2000); HemaSure which merged with Point Therapeutics (OTC BB: POTP.OB); BioSepra, now known as BioSphere Medical (Nasdaq: BSMD); and Versicor which became known as Vicuron Pharmaceuticals and which was subsequently acquired by Pfizer.

Prior to founding Sepracor, Mr. Barberich spent 10 years at Millipore Corporation, a Bedford, Massachusetts-based company that provides leading separations products to diversified market segments including the life science research, pharmaceutical, biotechnology and electronic markets. While at Millipore, he held a variety of marketing, sales, and general management positions. Prior to Millipore, Mr. Barberich held project management and research scientist positions at American Cyanamid Company.

Mr. Barberich serves as Chairman of the Board of Sepracor, and as a board member of BioSphere Medical, Point Therapeutics, PhRMA, the Pharmaceutical Research and Manufacturers of America, and Gemin X.

Back to Leadership